MS
A target hike, but not a love letter
HSBC just bumped its price target on Morgan Stanley to $177 from $153 while leaving the stock at Hold. So yes, the bank got a nicer math problem — but no, HSBC still isn’t exactly rushing the stage with confetti.
Why investors care
This comes right after Morgan Stanley’s Q1 beat, where it posted $3.43 in EPS versus $3.02 expected and $20.58 billion in revenue against $19.23 billion on Wall Street’s scoreboard. When a company beats like that, analysts tend to do a quick spreadsheet refresh and suddenly discover a more flattering haircut.
The catch: everybody loves the quarter, but not the stock
HSBC’s target is just one of several increases after the earnings pop, and the broader consensus target now sits around $199.67. Translation: the Street likes the numbers, but not everyone is ready to pay full retail for the shares.
One more wrinkle: insiders have been selling
The headline also lands alongside recent insider selling, with disclosures showing 129,191 shares sold over the past 90 days, worth about $23.7 million. Insider sales don’t always mean trouble, but they can make traders squint a little harder at the exit door.
Big picture: Morgan Stanley is having a pretty solid moment — strong earnings, rising targets, and a stock that’s getting more respect. But with HSBC still parked at Hold, this is more “nice recovery” than “all aboard.”